Clinical Evaluation of the Next Science SurgX Antimicrobial Wound Gel Impact on Surgical Site Complications

Northwell Health

Overview

This is a single-site, prospective, clinical study of subjects that are scheduled to undergo either total hip or total knee arthroplasties. It is anticipated that surgical wounds treated with SurgX will exhibit reduced surgical site complication rates and improved post-operative treatment outcomes by potentially decreasing site bioburden of both free-floating and biofilm-entrenched organisms.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Total Hip Arthroplasty Total Knee Arthroplasty

Interventions

SurgX Antimicrobial Wound GelOTHER

In addition to standard of care, at time of surgery, SurgX applied on the incision after closure and then re-applied at the time of first bandage change on day of discharge.

Standard of CareOTHER

The control group will receive standard of care.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Male or female 18 years or older 2. Scheduled to undergo primary hip or knee arthroplasty 3. Willing and able to comply with all study procedures and be available for the duration of the study 4. Provide signed and dated informed consent Exclusion Criteria: 1. Unable to provide signed and dated informed consent 2. Unable or unwilling to comply with all study-related procedures 3. Known history of allergic reaction to any of the study products or its components, including any products used for standard of care (such as dressings or any coverings) 4. Subject with any mental impairment or condition that would make them unable to properly consent without use of LAR or additional subject protections 5. Subjects from a vulnerable population, in accordance with 45 CFR 46 Subparts B, C, and D

Locations (3)

North Shore University Hospital

Manhasset, New York, United States

Long Island Jewish Medical Center

New Hyde Park, New York, United States

Lenox Hill Hospital

New York, New York, United States

Outcomes

Primary Outcomes

Surgical site complication

Presence/absence of a surgical site complication. Surgical site complications to be defined as meeting at least one of the below criteria: 1. Bacterial or fungal infection as confirmed by PCR swabs 2. Hypertrophic scar formation as diagnosed by in-person assessment via the study investigator 3. Superficial granuloma formation as diagnosed by in-person assessment via study investigator 4. Wound dehiscence as diagnosed by in-person assessment via study investigator 5. Presence of discharge as diagnosed by in-person assessment via study investigator 6. Presence of wound redness as diagnosed by in-person assessment via study investigator 7. Presence of stitch abscess as diagnosed by in-person assessment via study investigator 8. Superficial surgical site infection as diagnosed by in-person assessment via study investigator in accordance with the NHSN SSI Checklist

Time frame: within 12 weeks of the index procedure

Secondary Outcomes

Wound images

Third party assessment of wound images taken with Tissue Analytics via blinded assessor to corroborate the investigator's assessment using the below criteria: 1. Hypertrophic scar formation 2. Superficial granulation 3. Wound dehiscence 4. Discharge 5. Wound redness 6. Stitch abscess

Time frame: 12 weeks after index procedure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.